Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 20 | 2022 | 48 | 5.570 |
Why?
|
| HIV-1 | 19 | 2017 | 223 | 3.530 |
Why?
|
| HIV Infections | 18 | 2022 | 460 | 3.060 |
Why?
|
| Simian Immunodeficiency Virus | 5 | 2022 | 14 | 2.500 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2022 | 15 | 2.280 |
Why?
|
| Viral Regulatory and Accessory Proteins | 9 | 2016 | 13 | 2.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 12 | 2016 | 108 | 1.800 |
Why?
|
| Histocompatibility Antigens Class I | 6 | 2016 | 17 | 1.400 |
Why?
|
| Human Immunodeficiency Virus Proteins | 5 | 2016 | 5 | 1.260 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2016 | 2 | 1.080 |
Why?
|
| Cytokines | 3 | 2022 | 226 | 1.060 |
Why?
|
| Lymphocytes | 3 | 2021 | 59 | 1.030 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 90 | 0.980 |
Why?
|
| HLA-C Antigens | 4 | 2016 | 10 | 0.960 |
Why?
|
| Down-Regulation | 5 | 2016 | 92 | 0.920 |
Why?
|
| Antigens, CD | 5 | 2012 | 51 | 0.880 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 5 | 2016 | 8 | 0.870 |
Why?
|
| Interferon-gamma | 5 | 2022 | 76 | 0.800 |
Why?
|
| Colon | 5 | 2022 | 137 | 0.720 |
Why?
|
| Immunity, Innate | 5 | 2022 | 58 | 0.610 |
Why?
|
| Intestinal Mucosa | 4 | 2020 | 184 | 0.580 |
Why?
|
| Macaca mulatta | 3 | 2022 | 56 | 0.580 |
Why?
|
| Receptors, Virus | 1 | 2016 | 5 | 0.550 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2010 | 17 | 0.520 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 37 | 0.510 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 14 | 0.490 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 2 | 2014 | 2 | 0.480 |
Why?
|
| Receptors, Natural Killer Cell | 4 | 2022 | 5 | 0.480 |
Why?
|
| Lymphocyte Activation | 4 | 2017 | 81 | 0.440 |
Why?
|
| Humans | 30 | 2021 | 26286 | 0.420 |
Why?
|
| Lymphocyte Subsets | 2 | 2014 | 7 | 0.410 |
Why?
|
| Receptors, Immunologic | 3 | 2007 | 28 | 0.410 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 103 | 0.400 |
Why?
|
| Animals | 5 | 2022 | 3538 | 0.370 |
Why?
|
| Cell Degranulation | 1 | 2010 | 5 | 0.370 |
Why?
|
| Granzymes | 2 | 2021 | 6 | 0.360 |
Why?
|
| Inflammation | 3 | 2022 | 265 | 0.360 |
Why?
|
| Salmonella typhimurium | 3 | 2021 | 4 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 186 | 0.350 |
Why?
|
| HIV | 2 | 2007 | 38 | 0.350 |
Why?
|
| Gene Products, vpr | 1 | 2009 | 1 | 0.340 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 13 | 0.340 |
Why?
|
| Interleukins | 2 | 2020 | 25 | 0.340 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 172 | 0.320 |
Why?
|
| HLA Antigens | 2 | 2004 | 15 | 0.300 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 4 | 0.290 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 5 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 11 | 0.290 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2007 | 9 | 0.290 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 19 | 0.290 |
Why?
|
| Flow Cytometry | 6 | 2017 | 110 | 0.290 |
Why?
|
| HLA-B Antigens | 4 | 2016 | 9 | 0.290 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 237 | 0.270 |
Why?
|
| Transcription Factors | 1 | 2007 | 159 | 0.270 |
Why?
|
| Stress, Psychological | 2 | 2018 | 212 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2015 | 24 | 0.240 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 3 | 2010 | 3 | 0.240 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 3 | 2010 | 4 | 0.240 |
Why?
|
| Genetic Vectors | 2 | 2006 | 55 | 0.230 |
Why?
|
| Cullin Proteins | 2 | 2015 | 2 | 0.210 |
Why?
|
| GPI-Linked Proteins | 4 | 2014 | 21 | 0.210 |
Why?
|
| Cell Line | 3 | 2010 | 252 | 0.210 |
Why?
|
| Th17 Cells | 1 | 2022 | 27 | 0.200 |
Why?
|
| Ruminococcus | 1 | 2021 | 1 | 0.190 |
Why?
|
| Acinetobacter | 1 | 2021 | 2 | 0.190 |
Why?
|
| Interleukin-15 | 1 | 2021 | 8 | 0.190 |
Why?
|
| Interleukin-17 | 1 | 2020 | 18 | 0.170 |
Why?
|
| DNA Damage | 2 | 2010 | 24 | 0.170 |
Why?
|
| Ligands | 3 | 2014 | 40 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2019 | 26 | 0.170 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 12 | 0.160 |
Why?
|
| Gram-Negative Bacteria | 1 | 2019 | 28 | 0.160 |
Why?
|
| Underage Drinking | 1 | 2018 | 1 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 1 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2018 | 7 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 45 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 69 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 53 | 0.150 |
Why?
|
| Interleukin-2 | 2 | 2008 | 23 | 0.150 |
Why?
|
| Receptors, CCR7 | 2 | 2015 | 7 | 0.150 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 18 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 78 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2018 | 122 | 0.150 |
Why?
|
| Conduct Disorder | 1 | 2017 | 1 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2009 | 152 | 0.140 |
Why?
|
| Facial Expression | 1 | 2017 | 15 | 0.140 |
Why?
|
| Dysbiosis | 1 | 2017 | 55 | 0.140 |
Why?
|
| Pattern Recognition, Visual | 1 | 2017 | 26 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 31 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2007 | 67 | 0.140 |
Why?
|
| Social Environment | 1 | 2017 | 78 | 0.140 |
Why?
|
| Emotions | 1 | 2017 | 79 | 0.140 |
Why?
|
| Cell Death | 1 | 2016 | 44 | 0.140 |
Why?
|
| Receptors, KIR3DL1 | 1 | 2016 | 1 | 0.130 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2016 | 1 | 0.130 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 50 | 0.130 |
Why?
|
| Peptides | 1 | 2016 | 98 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 10 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2014 | 81 | 0.120 |
Why?
|
| Cell Movement | 1 | 2014 | 77 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2014 | 53 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2012 | 33 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2016 | 509 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2012 | 4 | 0.110 |
Why?
|
| Immunophenotyping | 2 | 2014 | 29 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2012 | 30 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 1157 | 0.100 |
Why?
|
| Male | 5 | 2020 | 14162 | 0.100 |
Why?
|
| Female | 5 | 2020 | 14539 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2010 | 39 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2009 | 13 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 119 | 0.080 |
Why?
|
| Stem Cells | 1 | 2009 | 39 | 0.080 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 53 | 0.080 |
Why?
|
| Apoptosis | 1 | 2010 | 195 | 0.080 |
Why?
|
| Gene Expression | 1 | 2009 | 181 | 0.080 |
Why?
|
| Monocytes, Activated Killer | 1 | 2008 | 1 | 0.080 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 13 | 0.080 |
Why?
|
| Viremia | 1 | 2007 | 9 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 1643 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 32 | 0.070 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2007 | 1 | 0.070 |
Why?
|
| CD48 Antigen | 1 | 2007 | 3 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2007 | 29 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 70 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2006 | 2 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 14 | 0.070 |
Why?
|
| Lentivirus | 1 | 2006 | 11 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2004 | 9 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 15 | 0.060 |
Why?
|
| Receptors, KIR | 1 | 2004 | 1 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 2 | 0.060 |
Why?
|
| K562 Cells | 1 | 2004 | 3 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 133 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 163 | 0.060 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 8 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 28 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2003 | 41 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 2080 | 0.050 |
Why?
|
| Time Factors | 1 | 2004 | 1391 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 23 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 2019 | 22 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2018 | 10 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 95 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 69 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 201 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 55 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 36 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2017 | 18 | 0.040 |
Why?
|
| Amygdala | 1 | 2017 | 40 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2017 | 71 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 378 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2015 | 1 | 0.030 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 20 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2015 | 26 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 15 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 15 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 51 | 0.030 |
Why?
|
| Protein Binding | 1 | 2014 | 113 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 853 | 0.030 |
Why?
|
| Chemokine CCL19 | 1 | 2014 | 3 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2014 | 2 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 58 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2014 | 11 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 11 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 5 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 29 | 0.030 |
Why?
|
| Virus Release | 1 | 2012 | 5 | 0.030 |
Why?
|
| Binding Sites | 1 | 2012 | 65 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2012 | 135 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 51 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 72 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2012 | 69 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 7448 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 8601 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 46 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 1886 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 200 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 162 | 0.020 |
Why?
|
| Retina | 1 | 2006 | 7 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 25 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 25 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 41 | 0.020 |
Why?
|
| Injections | 1 | 2006 | 44 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 27 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 372 | 0.020 |
Why?
|
| Mice | 1 | 2006 | 1290 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1538 | 0.010 |
Why?
|